Signaling pathways
-
A3272 Calcipotriol monohydrateSummary: A synthetic vitamin D3 analogue -
A9078 Z-FY-CHOSummary: Z-FY-CHO is a potent and specific cathepsin L inhibitor. -
A9082 Taurocholic acid-d4Summary: Taurocholic acid-d4 is deuterium labeled Taurocholic acid. It intended for use as an internal standard for the quantification of TCA by GC- or LC-MS. -
A9083 L-Cysteine-¹³C3Summary: L-Cysteine-¹³C3 is the ¹³C-labeled L-Cysteine. It acts as a precursor for biologically active molecules such as hydrogen sulphide (H2S), glutathione and taurine. L-Cysteine suppresses ghrelin and reduces appetite in rodents and humans. -
A9076 Taurolithocholic Acid MaxSpec® StandardSummary: Taurolithocholic acid is a quantitative analytical standard guaranteed to meet MaxSpec identity, purity, stability, and concentration specifications. -
A9077 Prostaglandin F2α ethanolamideSummary: Prostaglandin F2α ethanolamide is an ethanolamide-class G protein-coupled receptor (GPCR). It also acts as a luteolytic hormone in sheep and may serve as a nociceptive mediator in the spinal cord. -
BA2315 PolatuzumabSummary: Polatuzumab is a monoclonal antibody with a chemotherapeutically active molecule. - BA2316 InotuzumabSummary: Inotuzumab (HumanizedAnti-CD22RecombinantAntibody) is humanized, κ-antibody targeted to humans.
- BA2317 IzeltabartSummary: Izeltabart is a high affinity humanized antibody that targets.
- BA2318 LifastuzumabSummary: Lifastuzumab is a humanized anti-monoclonal antibody (IgG1 type).